Skip to main content

LifeStance Health Group, Inc. (LFST) Stock Forecast 2025 - AI Price Prediction & Analysis


LifeStance Health Group, Inc. (LFST) AI Stock Price Forecast & Investment Analysis

LifeStance Health Group, Inc. Stock Price Chart and Technical Analysis

Loading LifeStance Health Group, Inc. interactive price chart and technical analysis...

LifeStance Health Group, Inc. (LFST) - Comprehensive Stock Analysis & Investment Research

Deep dive into LifeStance Health Group, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about LifeStance Health Group, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For LifeStance Health Group, Inc.: LifeStance Health Group, Inc. operates in the Industrial Applications and Services sector, establishing it as a mid-cap growth opportunity.

LifeStance Health Group, Inc. (Stock Symbol: LFST) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Health Services industry.

The organization employs approximately 2485 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing LifeStance Health Group, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For LifeStance Health Group, Inc.: With $1316M in annual revenue and -7.9% net margin, the company demonstrates developing profitability.

Annual Revenue: $1316 million generating a -7.9% net profit margin .

Market Capitalization: $2031 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -28.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for LifeStance Health Group, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For LifeStance Health Group, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for LifeStance Health Group, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: LifeStance Health Group, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For LifeStance Health Group, Inc.: Market positioning analysis based on available financial and operational metrics.

LifeStance Health Group, Inc. strategically competes in the highly dynamic Services-Health Services marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 100.0% gross margin, indicating strong pricing power and operational efficiency.

LifeStance Health Group, Inc. (LFST) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for LifeStance Health Group, Inc. stock analysis.

Loading LifeStance Health Group, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into LifeStance Health Group, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if LifeStance Health Group, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For LifeStance Health Group, Inc.: With a P/E ratio of -0.01, the market sees the stock as potentially undervalued.

P/E Ratio -0.01x
P/B Ratio 1.38x
Market Cap $2031M
EPS $-0.04
Book Value/Share $3.79
Revenue/Share $3.38
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently LifeStance Health Group, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For LifeStance Health Group, Inc.: An ROE of -28.9% indicates room for improvement in shareholder value creation.

ROE -28.9%
ROA -20.3%
ROIC -21.5%
Gross Margin 100.0%
Operating Margin -5.4%
Net Margin -7.9%
EBT Margin -53.7%
Tax Rate 28.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess LifeStance Health Group, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For LifeStance Health Group, Inc.: A current ratio of 2.10 indicates strong liquidity.

Current Ratio 2.10x
Quick Ratio 1.66x
D/E Ratio 0.12x
Financial Leverage 1.27x
Interest Coverage -10.6x
Working Capital $-28M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal LifeStance Health Group, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For LifeStance Health Group, Inc.: Free cash flow of $-109M indicates cash challenges that need attention.

Operating Cash Flow $3M
Free Cash Flow $-109M
Capital Spending $-111M
FCF/Sales -14.9%
CapEx/Sales 15.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively LifeStance Health Group, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For LifeStance Health Group, Inc.: An asset turnover of 0.41x suggests room for improvement in asset utilization.

Asset Turnover 0.41x
Receivables Turnover 10.2x
Fixed Assets Turnover 6.0x
Days Sales Outstanding 36 days
Payables Period 7 days
Understanding Financial Statement Data

What these metrics mean: Key figures from LifeStance Health Group, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For LifeStance Health Group, Inc.: With annual revenue of $1316M, LifeStance Health Group, Inc. operates at significant scale.

Income Statement ($ Millions)
Total Revenue $1316M
SG&A Expense $69M
Cost of Goods Sold $-159M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 13%
Cash & Short-term Investments 6%
Total Liabilities 21%
Short-term Debt 0%
Accounts Receivable 5%
Dividend & Shareholder Information
Shares Outstanding 389M
Growth Metrics (YoY)
EPS Growth -7790.6%

Latest LifeStance Health Group, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting LifeStance Health Group, Inc. (LFST) stock price and investment outlook.

, source: Business Insider

Lifestance Health Group, Inc. ( (LFST)) has released its Q3 earnings. Here is a breakdown of the information Lifestance Health Group, Inc. presented to its investors. LifeStance Health Group, Inc., ...

, source: Benzinga.com

LifeStance Health shares are trading lower by 19.8% during Wednesday's session. The company announced pricing of a 20 million share offering by selling stockholders. 9 Out of the Last 10 Summers this ...

LifeStance Health Group, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of LifeStance Health Group, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ATPC Unlock Forecast - 30 Days FREE Trial $64M x 2.8x
DCGO Unlock Forecast - 30 Days FREE Trial $143M 15.5x 0.5x
EUDA Unlock Forecast - 30 Days FREE Trial $-73M -10.7x -17.5x
EUDAW Unlock Forecast - 30 Days FREE Trial $2M x -0.4x
INNV Unlock Forecast - 30 Days FREE Trial $578M -31.1x 2.4x
KDLY Unlock Forecast - 30 Days FREE Trial $83M x 54.4x
KDLYW Unlock Forecast - 30 Days FREE Trial $2M x 0.7x
LDDD Unlock Forecast - 30 Days FREE Trial $166M x 166.1x
LFST Unlock Forecast - 30 Days FREE Trial $2031M 0.0x 1.4x
NAKA Unlock Forecast - 30 Days FREE Trial $23M x 2.5x
NAKAW Unlock Forecast - 30 Days FREE Trial $30M x 3.4x
OMDA Unlock Forecast - 30 Days FREE Trial $1259M x 5.9x
PIII Unlock Forecast - 30 Days FREE Trial $0M -0.3x 0.0x
PIIIW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
PNTG Unlock Forecast - 30 Days FREE Trial $961M 35.8x 3.1x
PRVA Unlock Forecast - 30 Days FREE Trial $3135M 211.2x 4.6x
TALK Unlock Forecast - 30 Days FREE Trial $416M -81.9x 3.7x
TALKW Unlock Forecast - 30 Days FREE Trial $37M x 0.3x
USPH Unlock Forecast - 30 Days FREE Trial $1881M 49.3x 3.8x
VSEE Unlock Forecast - 30 Days FREE Trial $0M -1.3x -1.9x
VSEEW Unlock Forecast - 30 Days FREE Trial $0M x -0.1x
WGS Unlock Forecast - 30 Days FREE Trial $2295M -19.3x 8.9x
WGSWW Unlock Forecast - 30 Days FREE Trial $7M x 0.0x

Frequently Asked Questions - LifeStance Health Group, Inc. Stock Forecast

How accurate are LifeStance Health Group, Inc. stock predictions?

Our AI model demonstrates 51% historical accuracy for LFST predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence LifeStance Health Group, Inc. stock price forecasts?

Our analysis considers LifeStance Health Group, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is LifeStance Health Group, Inc. a good investment in 2025?

Based on our AI analysis, LifeStance Health Group, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are LifeStance Health Group, Inc. forecasts updated?

LifeStance Health Group, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced LifeStance Health Group, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for LifeStance Health Group, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...